WellPoint Hopes To Curb Relenza Costs By Pushing Flu Vaccination
WellPoint Health Networks is encouraging flu vaccinations in 280,000 letters to members, as part of a campaign to limit use of Glaxo Wellcome's influenza treatment Relenza.
WellPoint Health Networks is encouraging flu vaccinations in 280,000 letters to members, as part of a campaign to limit use of Glaxo Wellcome's influenza treatment Relenza.